This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

Marc Lemaitre, PhD
Consultant at ML Consult

Profile

Marc Lemaître holds a MSc in Organic Chemistry and a PhD in Biochemistry. Since 1985 Marc’s professional interests has been the study and manufacturing of Nucleic Acids therapeutic as well as for diagnostic applications.

Since 2013 Marc is working as independent consultant specialized in Oligonucleotide CMC and regulatory. He was member of the Board of Directors of the Oligonucleotide Therapeutics Society (2015-2021) and is currently Expert for USP

Agenda Sessions

  • Workshop Co-Moderators' Welcome and Opening Remarks

    09:00
  • Control Strategies and Regulatory Considerations

    10:45
  • Open DIscuession and Q&A with Workshop Speakers

    11:30